CN114085192B - 一种钆特醇中间体的精制方法 - Google Patents
一种钆特醇中间体的精制方法 Download PDFInfo
- Publication number
- CN114085192B CN114085192B CN202111654500.3A CN202111654500A CN114085192B CN 114085192 B CN114085192 B CN 114085192B CN 202111654500 A CN202111654500 A CN 202111654500A CN 114085192 B CN114085192 B CN 114085192B
- Authority
- CN
- China
- Prior art keywords
- formula
- compound
- gadoteridol
- intermediate compound
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229960005451 gadoteridol Drugs 0.000 title claims abstract description 51
- DPNNNPAKRZOSMO-UHFFFAOYSA-K gadoteridol Chemical compound [Gd+3].CC(O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1 DPNNNPAKRZOSMO-UHFFFAOYSA-K 0.000 title claims abstract description 44
- 238000000034 method Methods 0.000 title claims abstract description 22
- 238000007670 refining Methods 0.000 title abstract description 4
- 150000001875 compounds Chemical class 0.000 claims abstract description 69
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims abstract description 12
- BNWCETAHAJSBFG-UHFFFAOYSA-N tert-butyl 2-bromoacetate Chemical compound CC(C)(C)OC(=O)CBr BNWCETAHAJSBFG-UHFFFAOYSA-N 0.000 claims abstract description 12
- 238000006243 chemical reaction Methods 0.000 claims description 36
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 18
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 6
- 239000002585 base Substances 0.000 claims description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- 239000003054 catalyst Substances 0.000 claims description 4
- SHFJWMWCIHQNCP-UHFFFAOYSA-M hydron;tetrabutylazanium;sulfate Chemical compound OS([O-])(=O)=O.CCCC[N+](CCCC)(CCCC)CCCC SHFJWMWCIHQNCP-UHFFFAOYSA-M 0.000 claims description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
- 239000001632 sodium acetate Substances 0.000 claims description 4
- 235000017281 sodium acetate Nutrition 0.000 claims description 4
- DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 3
- KXHPPCXNWTUNSB-UHFFFAOYSA-M benzyl(trimethyl)azanium;chloride Chemical group [Cl-].C[N+](C)(C)CC1=CC=CC=C1 KXHPPCXNWTUNSB-UHFFFAOYSA-M 0.000 claims description 3
- 239000007810 chemical reaction solvent Substances 0.000 claims description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethyl sulfoxide Natural products CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000012458 free base Substances 0.000 claims description 3
- QLPMKRZYJPNIRP-UHFFFAOYSA-M methyl(trioctyl)azanium;bromide Chemical compound [Br-].CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC QLPMKRZYJPNIRP-UHFFFAOYSA-M 0.000 claims description 3
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 2
- 235000011181 potassium carbonates Nutrition 0.000 claims description 2
- 235000011118 potassium hydroxide Nutrition 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 235000017550 sodium carbonate Nutrition 0.000 claims description 2
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical group [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 claims 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims 1
- 235000017557 sodium bicarbonate Nutrition 0.000 claims 1
- 239000012535 impurity Substances 0.000 abstract description 19
- -1 impurity D compound Chemical class 0.000 abstract description 14
- 230000015572 biosynthetic process Effects 0.000 abstract description 9
- 238000003786 synthesis reaction Methods 0.000 abstract description 7
- 238000009776 industrial production Methods 0.000 abstract description 4
- 238000000746 purification Methods 0.000 abstract description 4
- 238000006555 catalytic reaction Methods 0.000 abstract 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 20
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 238000001514 detection method Methods 0.000 description 18
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 5
- 229910052688 Gadolinium Inorganic materials 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 229940075613 gadolinium oxide Drugs 0.000 description 4
- 229910001938 gadolinium oxide Inorganic materials 0.000 description 4
- CMIHHWBVHJVIGI-UHFFFAOYSA-N gadolinium(iii) oxide Chemical compound [O-2].[O-2].[O-2].[Gd+3].[Gd+3] CMIHHWBVHJVIGI-UHFFFAOYSA-N 0.000 description 4
- 238000002595 magnetic resonance imaging Methods 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 3
- 230000004807 localization Effects 0.000 description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 description 3
- 238000013421 nuclear magnetic resonance imaging Methods 0.000 description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- AAEQXEDPVFIFDK-UHFFFAOYSA-N 3-(4-fluorobenzoyl)-2-(2-methylpropanoyl)-n,3-diphenyloxirane-2-carboxamide Chemical compound C=1C=CC=CC=1NC(=O)C1(C(=O)C(C)C)OC1(C=1C=CC=CC=1)C(=O)C1=CC=C(F)C=C1 AAEQXEDPVFIFDK-UHFFFAOYSA-N 0.000 description 2
- DJOWTWWHMWQATC-KYHIUUMWSA-N Karpoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1(O)C(C)(C)CC(O)CC1(C)O)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C DJOWTWWHMWQATC-KYHIUUMWSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229940040526 anhydrous sodium acetate Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000002872 contrast media Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 238000002386 leaching Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000002663 nebulization Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
Abstract
Description
时间(分钟) | 流动相A(%) | 流动相B(%) |
0 | 100 | 0 |
15 | 100 | 0 |
30 | 75 | 25 |
40 | 100 | 0 |
保留时间(min) | 峰面积 | 峰面积百分比(%) | 峰高 | 峰宽(min) | 分离度(USP) |
18.659 | 11.549 | 0.28 | 4.69 | 0.07 | |
19.049 | 7.729 | 0.19 | 3.31 | 0.07 | 6.12 |
20.143 | 4148.199 | 99.42 | 759.46 | 0.54 | 10.59 |
20.648 | 4.791 | 0.11 | 1.19 | 0.20 | 3.99 |
总计 | 4172.27 |
保留时间(min) | 峰面积 | 峰面积百分比(%) | 峰高 | 峰宽(min) | 分离度(USP) |
17.971 | 10.235 | 0.13 | 3.18 | 0.12 | |
18.303 | 17.264 | 0.22 | 5.66 | 0.10 | 3.95 |
18.652 | 21.001 | 0.27 | 5.97 | 0.12 | 3.93 |
20.788 | 7695.531 | 99.15 | 873.04 | 0.46 | 12.28 |
24.327 | 17.486 | 0.23 | 3.09 | 0.54 | 18.20 |
总计 | 776152 |
保留时间(min) | 峰面积 | 峰面积百分比(%) | 峰高 | 峰宽(min) | 分离度(USP) |
17.952 | 8.45 | 0.11 | 1.95 | 0.29 | |
18.298 | 28.31 | 0.38 | 6.08 | 0.34 | 3.02 |
18.641 | 22.92 | 0.31 | 4.16 | 0.50 | 2.81 |
19.289 | 6.81 | 0.09 | 1.84 | 0.14 | 5.73 |
19.415 | 7.45 | 0.10 | 1.85 | 0.18 | 1.22 |
20.773 | 7283.63 | 98.63 | 868.03 | 0.42 | 7.88 |
21.133 | 15.34 | 0.21 | 3.93 | 0.15 | 2.11 |
21.517 | 2.87 | 0.04 | 0.72 | 0.15 | 3.61 |
22.626 | 6.31 | 0.09 | 0.86 | 0.32 | 7.23 |
24.215 | 3.07 | 0.04 | 0.68 | 0.18 | 9.99 |
总计 | 7385.16 |
保留时间(min) | 峰面积 | 峰面积百分比(%) | 峰高 | 峰宽(min) | 分离度(USP) |
15.385 | 66.42 | 0.22 | 11.37 | 0.26 | |
16.181 | 40.58 | 0.14 | 10.90 | 0.22 | 6.40 |
17.283 | 23.27 | 0.08 | 5.94 | 0.21 | 11.18 |
17.859 | 101.50 | 0.34 | 24.26 | 0.30 | 5.53 |
18.169 | 378.40 | 1.27 | 88.99 | 0.37 | 2.87 |
18.549 | 193.68 | 0.65 | 36.40 | 0.50 | 3.31 |
19.027 | 8.41 | 0.03 | 2.35 | 0.14 | 4.38 |
19.161 | 63.40 | 0.21 | 18.85 | 0.12 | 1.44 |
19.273 | 114.23 | 0.38 | 30.76 | 0.16 | 1.15 |
20.441 | 28354.34 | 95.51 | 1985.55 | 0.60 | 4.79 |
20.994 | 172.63 | 0.58 | 42.17 | 0.19 | 2.23 |
21.356 | 29.72 | 0.10 | 6.88 | 0.19 | 3.22 |
21.532 | 6.89 | 0.02 | 1.47 | 0.18 | 1.45 |
24.058 | 134.54 | 0.45 | 25.02 | 0.47 | 19.86 |
总计 | 29687.98 |
保留时间(min) | 峰面积 | 峰面积百分比(%) | 峰高 | 峰宽(min) | 分离度(USP) |
4.165 | 1.610 | 0.04 | 0.54 | 0.09 | |
4.279 | 155.296 | 3.79 | 25.49 | 0.54 | 0.46 |
16.101 | 1.568 | 0.04 | 0.47 | 0.08 | 76.23 |
16.212 | 84.693 | 2.07 | 23.69 | 0.24 | 0.88 |
16.737 | 9.389 | 0.23 | 0.82 | 0.29 | 2.38 |
16.968 | 7.917 | 0.19 | 0.55 | 0.41 | 0.46 |
17.410 | 24.029 | 0.59 | 5.51 | 0.57 | 1.15 |
17.993 | 2.896 | 0.07 | 0.69 | 0.27 | 5.49 |
18.354 | 104.016 | 2.54 | 22.04 | 0.36 | 3.28 |
18.698 | 19.561 | 0.48 | 3.54 | 0.53 | 2.86 |
19.383 | 2.460 | 0.06 | 0.45 | 0.41 | 5.33 |
20.872 | 3665.530 | 89.43 | 578.76 | 0.37 | 9.84 |
21.172 | 3.350 | 0.08 | 0.97 | 0.11 | 2.27 |
21.543 | 3.044 | 0.07 | 0.60 | 0.30 | 3.42 |
24.203 | 13.499 | 0.33 | 2.52 | 0.53 | 20.66 |
总计 | 4098.86 |
保留时间(min) | 峰面积 | 峰面积百分比(%) | 峰高 | 峰宽(min) | 分离度(USP) |
14.905 | 7.35 | 0.03 | 0.77 | 0.42 | |
15.474 | 10.43 | 0.04 | 1.57 | 0.20 | 2.66 |
16.176 | 14.19 | 0.05 | 3.88 | 0.23 | 5.38 |
16.495 | 11.00 | 0.04 | 3.18 | 0.22 | 3.47 |
17.852 | 68.80 | 0.25 | 15.39 | 0.33 | 13.70 |
18.169 | 27.59 | 0.10 | 9.66 | 0.09 | 3.44 |
18.269 | 261.42 | 0.94 | 69.82 | 0.16 | 1.13 |
18.543 | 131.95 | 0.47 | 24.39 | 0.43 | 2.46 |
19.149 | 37.77 | 0.14 | 10.91 | 0.13 | 5.62 |
19.265 | 48.43 | 0.17 | 13.17 | 0.15 | 1.20 |
20.467 | 24433.79 | 87.71 | 1835.72 | 0.59 | 5.14 |
20.998 | 24.24 | 0.09 | 6.34 | 0.15 | 2.27 |
21.366 | 14.20 | 0.05 | 3.12 | 0.15 | 3.21 |
21.510 | 24.95 | 0.09 | 5.73 | 0.17 | 1.18 |
22.434 | 16.02 | 0.06 | 1.87 | 0.27 | 5.25 |
22.662 | 26.84 | 0.10 | 5.50 | 0.34 | 1.28 |
23.285 | 169.25 | 0.61 | 14.86 | 0.36 | 2.89 |
23.931 | 2528.54 | 9.08 | 277.14 | 0.63 | 2.30 |
总计 | 27856.75 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111654500.3A CN114085192B (zh) | 2021-12-30 | 2021-12-30 | 一种钆特醇中间体的精制方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111654500.3A CN114085192B (zh) | 2021-12-30 | 2021-12-30 | 一种钆特醇中间体的精制方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114085192A CN114085192A (zh) | 2022-02-25 |
CN114085192B true CN114085192B (zh) | 2023-09-19 |
Family
ID=80308283
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111654500.3A Active CN114085192B (zh) | 2021-12-30 | 2021-12-30 | 一种钆特醇中间体的精制方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114085192B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115160244B (zh) * | 2022-06-24 | 2023-08-11 | 厦门大学 | 一种三功能dota类螯合剂中间体的制备方法与应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1259939A (zh) * | 1997-06-11 | 2000-07-12 | 伯拉考公司 | 大环螯合剂及其与顺磁性金属离子的螯合物的制备方法 |
CN110835326A (zh) * | 2018-08-15 | 2020-02-25 | 正大天晴药业集团股份有限公司 | 大环螯合剂及其中间体的制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL3872157T3 (pl) * | 2020-02-27 | 2023-04-17 | Henkel Ag & Co. Kgaa | Środek do mycia naczyń zawierający kompleksy metali |
-
2021
- 2021-12-30 CN CN202111654500.3A patent/CN114085192B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1259939A (zh) * | 1997-06-11 | 2000-07-12 | 伯拉考公司 | 大环螯合剂及其与顺磁性金属离子的螯合物的制备方法 |
CN110835326A (zh) * | 2018-08-15 | 2020-02-25 | 正大天晴药业集团股份有限公司 | 大环螯合剂及其中间体的制备方法 |
Non-Patent Citations (2)
Title |
---|
Bhumasamudram Jagadish,等.On the synthesis of 1,4,7-tris(tert-butoxycarbonylmethyl)- 1,4,7,10-tetraazacyclododecane.《Tetrahedron Letters》.2010,第52卷2058–2061,第2061页第4.1节. * |
Qin Zhu,等.HP-DO3A-based amphiphilic MRI contrast agents and relaxation enhancement through their assembly with polyelectrolytes.《J. Mater. Chem. B》.2016,第4卷7241--7248,7243页右栏第2段. * |
Also Published As
Publication number | Publication date |
---|---|
CN114085192A (zh) | 2022-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9458117B2 (en) | Process for producing 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid and complexes thereof | |
CN114085192B (zh) | 一种钆特醇中间体的精制方法 | |
CN102762535B (zh) | 合成和分离n-(溴乙酰基)-3, 3-二硝基氮杂环丁烷的方法和包括其的组合物 | |
US20170007726A1 (en) | Process for purifying 1,4,7,10-tetra-azacyclododecane-1,4,7,10-tetraacetic acid | |
US20190062459A1 (en) | Method for preparation of sugammadex sodium | |
CN109432449B (zh) | 一种铁配合物mri造影剂及其制备方法与应用 | |
CN110357828B (zh) | 一种核磁共振造影剂及其制备方法和用途 | |
CN104086554B (zh) | 一种新型的完全水溶的光敏剂单体及其制备方法及应用 | |
CN110642907B (zh) | 普拉唑米星或其盐的合成方法 | |
KR100976762B1 (ko) | 아데포비어디피복실의 개선된 제조방법 | |
JP2002515493A (ja) | 熱的に安定なトリメトレキサートおよびその製造プロセス | |
CN108003198B (zh) | 一种d-半乳糖键接的开环葫芦脲及应用 | |
US8299283B2 (en) | Contrast agent containing silsesquioxane | |
WO2023084859A1 (ja) | 含フッ素化合物および造影剤 | |
CN114401957B (zh) | 一种喹唑啉衍生物的制备方法及其结晶 | |
CN112321592B (zh) | 一种6-氯咪唑并[1,2-b]哒嗪-3-甲腈的合成方法 | |
WO2022196523A1 (ja) | 含フッ素化合物および造影剤 | |
CN103421059B (zh) | 一种氨柔比星的合成方法 | |
US20240156994A1 (en) | Fluorine-containing compound and contrast medium | |
WO2022196621A1 (ja) | 含フッ素化合物および造影剤 | |
CN107501327B (zh) | 环磷酰胺—水物的结晶方法 | |
WO2004106355A1 (en) | Addition salts of azithromycin and citric acid and process for preparing them | |
JPH06206883A (ja) | 新規なヘマトポルフィリン類およびmri用診断薬 | |
JP3076883B2 (ja) | 新規なテトラフェニルポルフィン配糖体 | |
CN105669551B (zh) | 7‑苯并(c)吖啶对氟苯甲酰胺基硫脲及其制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240206 Address after: 246004 No. 58, xiahong Road, high tech Industrial Development Zone, Anqing City, Anhui Province Patentee after: Anhui Puli Pharmaceutical Co.,Ltd. Country or region after: China Address before: 571127 Guilin Ocean Economic Development Zone, Meilan District, Haikou City, Hainan Province Patentee before: HAINAN POLY PHARM. Co.,Ltd. Country or region before: China Patentee before: ZHEJIANG POLY PHARMACEUTICAL Co.,Ltd. Patentee before: Anhui Puli Pharmaceutical Co.,Ltd. |